Already this year, OIKOS is growing in the mid-double digits in retail dollar sales, Acevedo reveals
Future prospective, randomized studies with larger cohorts, longer follow-up periods, structured comorbidity assessment, and objective monitoring of lifestyle adherence are warranted to confirm and extend these findings
Last reviewed: June 4, 2026 Last updated: June 4, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
If you would like to continue using a lower dose of Wegovy beyond the recommended four-week window, discuss your plans with a licensed clinician first